Health Insurance Innovations should be bought aggressively, says Canaccord

Canaccord analyst Richard Close said he would be an aggressive buyer of Health Insurance Innovations shares following its significant pullback. The analyst cited the company’s recently updated guidance and his management meeting, which reassured him about the company’s focus on compliance and the potential for accelerating growth given industry tailwinds. Close reiterated his Buy rating and $62 price target on Health Insurance Innovations shares.
https://thefly.com/landingPageNews.php?id=2840527